Sign In
Buy TTI
$7.70
+0.0800 (+1.05%)
At Close: Jul 31, 2026
TETRA TECHNOLOGIES, INC. TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
08:00am, Wednesday, 07'th Jan 2026
SPRING, Texas, Jan. 7, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) announced that its senior management will be participating in the following investor conferen
Thiogenesis to Present Clinical Updates in MELAS and Leigh Syndrome Spectrum at UMDF Bench-to-Bedside Webinar
09:00am, Monday, 05'th Jan 2026
Dr. Rioux Will Present on Phase 2 MELAS Program & Upcoming Phase 2a Leigh Syndrome Trial San Diego, California--(Newsfile Corp. - January 5, 2026) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX:
TETRA TECHNOLOGIES, INC. TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
08:00am, Tuesday, 09'th Dec 2025
SPRING, Texas , Dec. 9, 2025 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE: TTI) announced that its senior management will be participating in the following investor confer
TETRA TECHNOLOGIES, INC. AND MAGRATHEA METALS, INC.
06:00am, Tuesday, 02'nd Dec 2025
Critical mineral extraction represents another key step in ONE TETRA 2030 strategy SPRING, Texas , Dec. 2, 2025 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) announced
Tetra Technologies (NYSE:TTI) versus Core Laboratories (NYSE:CLB) Head to Head Review
02:14am, Tuesday, 02'nd Dec 2025
Tetra Technologies (NYSE: TTI - Get Free Report) and Core Laboratories (NYSE: CLB - Get Free Report) are both small-cap energy companies, but which is the superior investment? We will compare the two
TETRA TECHNOLOGIES, INC. TO PARTICIPATE IN THE WELLS FARGO 24TH ANNUAL ENERGY & POWER SYMPOSIUM
04:30pm, Monday, 01'st Dec 2025
SPRING, Texas , Dec. 1, 2025 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) announced that Brady Murphy, Chief Executive Officer, and Kurt Hallead, VP of Investor Relat
Thiogenesis Therapeutics Expands on Plans for Phase 3 Pivotal Trial of TTI-0102 in Nephropathic Cystinosis
09:00am, Monday, 24'th Nov 2025
IND expected in early 2026; TTI-0102 designed to improve tolerability & simplify dosing San Diego, California--(Newsfile Corp. - November 24, 2025) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX
Trial achieved biological proof-of-concept, dose discovery and biomarker improvement San Diego, California--(Newsfile Corp. - November 4, 2025) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TT
TETRA Technologies, Inc. (TTI) Q3 2025 Earnings Call Transcript
01:56pm, Wednesday, 29'th Oct 2025
TETRA Technologies, Inc. ( TTI ) Q3 2025 Earnings Call October 29, 2025 10:30 AM EDT Company Participants Kurt Hallead - Treasurer & VP of Investor Relations Brady Murphy - President, CEO & Director E
Tetra Technologies (TTI) Meets Q3 Earnings Estimates
07:16pm, Tuesday, 28'th Oct 2025
Tetra Technologies (TTI) came out with quarterly earnings of $0.04 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.03 per share a year ago.
TETRA TECHNOLOGIES, INC. ANNOUNCES STRONG THIRD QUARTER 2025 RESULTS
05:00pm, Tuesday, 28'th Oct 2025
Third Quarter 2025 Financial Highlights Revenue of $153 million increased 8% year over year Net income before taxes of $8.1 million was flat year over year Adjusted EBITDA of $25.0 million increased 7
TETRA TECHNOLOGIES, INC. ANNOUNCES CFO TRANSITION WITH PLANNED RETIREMENT OF ELIJIO SERRANO AND APPOINTMENT OF MATT SANDERSON
08:00am, Monday, 27'th Oct 2025
CHANGES REFLECT TETRA'S SUCCESSION PLANNING PROCESS THE WOODLANDS, Texas , Oct. 27, 2025 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE: TTI) announced today that Elijio Ser
TETRA TECHNOLOGIES, INC. ANNOUNCES THIRD QUARTER 2025 EARNINGS RELEASE CONFERENCE CALL AND WEBCAST
05:45pm, Monday, 13'th Oct 2025
THE WOODLANDS, Texas , Oct. 13, 2025 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) announced today that it will release third quarter 2025 results after the closing of
Tetra Technologies (TTI) Moves 5.2% Higher: Will This Strength Last?
01:06pm, Tuesday, 07'th Oct 2025
Tetra Technologies (TTI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength do
Thiogenesis Announces Extension to Investor Relations Agreement
04:00pm, Friday, 03'rd Oct 2025
San Diego, California--(Newsfile Corp. - October 3, 2025) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (Thiogenesis or the Company) a clinical-stage biotechnology company developing disulfides that d
